首页 | 本学科首页   官方微博 | 高级检索  
     检索      

大黄素和黄芪多糖对大鼠实验性肝癌的抑制作用
引用本文:党双锁,张正国,袁利超,王宝峰,张欣,宋平,程延安.大黄素和黄芪多糖对大鼠实验性肝癌的抑制作用[J].西安交通大学学报(医学版),2006,27(3):250-253.
作者姓名:党双锁  张正国  袁利超  王宝峰  张欣  宋平  程延安
作者单位:1. 西安交通大学医学院第二附属医院感染科,陕西,西安,710004
2. 中日友好医院感染科,北京,100029
基金项目:国家自然科学基金资助项目(No.30472266)
摘    要:目的研究大黄素与黄芪多糖对大鼠实验性肝癌的抑制作用并探讨其机制。方法采用二乙基亚硝胺(dieth-ylnitrosamine,DEN)诱发大鼠肝癌模型。50只清洁级雄性SD大鼠随机分为5组:正常对照组、肝癌模型组(DEN诱癌)、大黄素组(诱癌同时给大黄素)、黄芪多糖组(诱癌同时给黄芪多糖)、大黄素和黄芪多糖联合给药组(诱癌同时联合用大黄素和黄芪多糖干预),每组10只。联合灌胃14周。实验第18周处死所有大鼠,检测血清ALT、ALP、γ-GT和AFU,并行肝脏病理检查,用SABC法检测谷胱甘肽-S-转移酶(GST-P)、转化生长因子β1(TGF-β1)的表达情况。结果造模各组大鼠的ALT、ALP、-γGT、AFU均明显升高(P<0.05),两种药物干预可以减轻肝脏损害(P<0.05)。病理检查证实各实验组大鼠均诱发出肝癌。两种药物均能减少GST-P和TGF-β1的表达(P<0.05),但联合应用未显示明显的协同作用。结论大黄素、黄芪多糖干预治疗可以减轻肝损害,降低肝癌标志物GST-P的表达。抑癌作用可能与这两种药物抑制了肝癌组织TGF-β1的表达有关。

关 键 词:大黄素  黄芪多糖  肝癌
文章编号:1671-8259(2006)03-0250-04
收稿时间:2005-12-02
修稿时间:2005-12-28

Effects of emodin and astragalus polysaccharides on the expressions of GST-P and TGF-β1 in rats' hepatocellular carcinoma constitution
Dang Shuangsuo,Zhang Zhengguo,Yuan Lichao,Wang Baofeng,Zhang Xin,Song Ping,Chen Yan'an.Effects of emodin and astragalus polysaccharides on the expressions of GST-P and TGF-β1 in rats'''' hepatocellular carcinoma constitution[J].Journal of Xi‘an Jiaotong University:Medical Sciences,2006,27(3):250-253.
Authors:Dang Shuangsuo  Zhang Zhengguo  Yuan Lichao  Wang Baofeng  Zhang Xin  Song Ping  Chen Yan'an
Abstract:Objective To study the inhibiting effect of emodin and astragalus polysaccharides on experimental hepatocarcinoma in rats and to explore its possible mechanism.Methods Hepatocarcinogenesis model rat was induced by diethylnitrosamine(DEN).Fifty SD male rats were randomly divided into 5 groups: normal control group,hepatocarcinogenesis model group(induced by DEN),emodin group,astragalus polysaccharides group,combined emodin with astragalus polysaccharides group.Rats were administered with emodin and astragalus polysaccharides when they were induced by DEN.All rats were killed in the 18~(th) week,Then serum ALT,ALP,γ-GT,α-L-fucoxidase(AFU) was detected.All rats' livers were observed by routine histological.GST-P and TGF-β_(1) were tested with SABC.Results The results of liver function in the 18~(th) week displayed that ALT,ALP,γ-GT and AFU of all groups were increased than that of negative control(P<0.05).The two drugs could relieve hepatic injures.88% of rats were induced to hepatocellular carcinoma confirmed by HE staining.The expressions of GST-P and TGF-β_1 in normal control were higher than that in groups which used emodin and astragalus polysaccharides((P<0.05)).Conclusion Emodin and astragalus polysaccharides can relieve hepatic injure and inhibit the expression of GST-P and TGF-β_1.The inhibiting effect on TGF-β_1 may be one of the mechanisms to control hepatocarcinoma.
Keywords:emodin  astragalus polysaccharides  hepatocellular carcinoma  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号